These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 7030786)
1. Inhibition of subtilisin by substituted arylboronic acids. Philipp M; Maripuri S FEBS Lett; 1981 Oct; 133(1):36-8. PubMed ID: 7030786 [No Abstract] [Full Text] [Related]
2. Inhibition of subtilisin by boronic acids, potential analogs of tetrahedral reaction intermediates. Lindquist RN; Terry C Arch Biochem Biophys; 1974 Jan; 160(1):135-44. PubMed ID: 4364061 [No Abstract] [Full Text] [Related]
3. Probing the specificity of the S1 binding site of subtilisin Carlsberg with boronic acids. Seufer-Wasserthal P; Martichonok V; Keller TH; Chin B; Martin R; Jones JB Bioorg Med Chem; 1994 Jan; 2(1):35-48. PubMed ID: 7922119 [No Abstract] [Full Text] [Related]
4. Probing the specificity of the S1 binding site of subtilisin Carlsberg with boronic acids. Keller TH; Seufer-Wasserthal P; Jones JB Biochem Biophys Res Commun; 1991 Apr; 176(1):401-5. PubMed ID: 2018529 [TBL] [Abstract][Full Text] [Related]
5. Kinetic studies on the binding of Streptomyces subtilisin inhibitor with subtilisin BPN. Uehara Y; Tonomura B; Hiromi K Arch Biochem Biophys; 1980 Jun; 202(1):250-8. PubMed ID: 6994658 [No Abstract] [Full Text] [Related]
6. Dansylation of Streptomyces subtilisin inhibitor: spectrometric analysis of the fluorescence-labeled inhibitor. Tanizawa K; Moriya K; Kanaoka Y Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2606-9. PubMed ID: 2285993 [TBL] [Abstract][Full Text] [Related]
7. Comparative characterization of the substrate-binding subsites in subtilisins DY and Carlsberg by fluorescence and kinetic studies. Boteva R; Dimov I; Genov N; Fittkau S; Peters K J Photochem Photobiol B; 1988 May; 1(4):461-8. PubMed ID: 3149293 [TBL] [Abstract][Full Text] [Related]
8. Subtilisin-catalyzed hydrolysis of peptide methyl esters. Philipp M; Bender ML FEBS Lett; 1974 Jun; 42(3):282-4. PubMed ID: 4854515 [No Abstract] [Full Text] [Related]
9. 2.4 A resolution crystal structure of the prototypical hormone-processing protease Kex2 in complex with an Ala-Lys-Arg boronic acid inhibitor. Holyoak T; Wilson MA; Fenn TD; Kettner CA; Petsko GA; Fuller RS; Ringe D Biochemistry; 2003 Jun; 42(22):6709-18. PubMed ID: 12779325 [TBL] [Abstract][Full Text] [Related]
10. The topographical differences in the active site region of alpha-chymotrypsin, subtilisin Novo, and subtilisin Carlsberg. Mapping the aromatic binding site by inhibitors (virtual substrates). Bosshard HR; Berger A Biochemistry; 1974 Jan; 13(2):266-77. PubMed ID: 4810052 [No Abstract] [Full Text] [Related]
11. Direct fluorometric determination of a dissociation constant as low as 10(-10) M for the subtilisin BPN'--protein proteinase inhibitor (Streptomyces subtilisin inhibitor) complex by a single photon counting technique. Uehara Y; Tonomura B; Hiromi K J Biochem; 1978 Nov; 84(5):1195-202. PubMed ID: 32173 [TBL] [Abstract][Full Text] [Related]
17. Fluorescence technique for comparative studies of substrate-binding subsites in serine proteinases. Application to subtilisins. Genov NC; Boteva RN Biochem J; 1986 Sep; 238(3):923-6. PubMed ID: 3541918 [TBL] [Abstract][Full Text] [Related]
18. Novel diphenyl esters of peptidyl alpha-aminoalkylphosphonates as inhibitors of chymotrypsin and subtilisin. Pietrusewicz E; Sieńczyk M; Oleksyszyn J J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1229-36. PubMed ID: 19912056 [TBL] [Abstract][Full Text] [Related]
19. Alizarin Red S. as a general optical reporter for studying the binding of boronic acids with carbohydrates. Springsteen G; Wang B Chem Commun (Camb); 2001 Sep; (17):1608-9. PubMed ID: 12240405 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of serine proteases by arylboronic acids. Philipp M; Bender ML Proc Natl Acad Sci U S A; 1971 Feb; 68(2):478-80. PubMed ID: 4993411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]